Psychotropic deprescribing in ethnic minority individuals with a learning disability requires a more nuanced approach

People from ethnic minority backgrounds who have a learning disability face ‘double discrimination’ when accessing healthcare services. Culturally sensitive psychotropic deprescribing is just one way this can be improved.
Illustration of two silhouetted black women's heads, overlapping to create a venn diagram, with pills being tipped into the overlapping space

Wes Mountain/The Pharmaceutical Journal

Health inequalities are pervasive across our healthcare system, affecting different patients in different ways and requiring an increasingly nuanced approach to tackle them.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated